NDC Code(s) : 52125-946-08
Packager : REMEDYREPACK INC.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Prevacidlansoprazole CAPSULE, DELAYED RELEASE | ||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
DRUG: Prevacid
GENERIC: lansoprazole
DOSAGE: CAPSULE, DELAYED RELEASE
ADMINSTRATION: ORAL
NDC: 52125-946-08
COLOR: pink
SHAPE: CAPSULE
SCORE: No score
SIZE: 19 mm
IMPRINT: TAP;PREVACID;30
PACKAGING: 10 in 1 BOTTLE
ACTIVE INGREDIENT(S):
- lansoprazole 30mg in 1
INACTIVE INGREDIENT(S):
- FD&C Red No. 40
- HYDROXYPROPYL CELLULOSE (TYPE H)
- polysorbate 80
- silicon dioxide
- D&C Red No. 28
- FD&C Blue No. 1
- titanium dioxide
- hydroxypropyl cellulose, low substituted
- methacrylic acid - ethyl acrylate copolymer (1:1) type A
- polyethylene glycols
- starch, corn
- magnesium carbonate
- sucrose
- talc